Skip to main content
. 2009 Jun 17;2:18. doi: 10.1186/1756-6606-2-18

Figure 5.

Figure 5

A novel mechanism of LTD involving liprin-α and LAR. Activation of mAChRs leads to a G-protein dependent mAChR-LTD that does not involve the canonical pathway (IP3 and PKC). The data can most simply be explained by GRIP acting as a targeting molecule that brings LAR and the GluA2 subunit of AMPARs into contact. This then enables LAR to dephosphorlyate a tyrosine residue (such as YGIESVKI on GluA2) which initiates the removal of the AMPAR from the synapse.

HHS Vulnerability Disclosure